132 related articles for article (PubMed ID: 26488807)
21. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
King D; Jarjoura D; McEwen HA; Askew MJ
J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
[TBL] [Abstract][Full Text] [Related]
22. Paradoxical effects of partial leptin deficiency on bone in growing female mice.
Philbrick KA; Turner RT; Branscum AJ; Wong CP; Iwaniec UT
Anat Rec (Hoboken); 2015 Dec; 298(12):2018-29. PubMed ID: 26370912
[TBL] [Abstract][Full Text] [Related]
23. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
Melville KM; Kelly NH; Khan SA; Schimenti JC; Ross FP; Main RP; van der Meulen MC
J Bone Miner Res; 2014 Feb; 29(2):370-9. PubMed ID: 24038209
[TBL] [Abstract][Full Text] [Related]
24. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
25. Rictor/mTORC2 loss in osteoblasts impairs bone mass and strength.
Liu DM; Zhao L; Liu TT; Jiao PL; Zhao DD; Shih MS; Tao B; Sun LH; Zhao HY; Liu JM
Bone; 2016 Sep; 90():50-8. PubMed ID: 27262777
[TBL] [Abstract][Full Text] [Related]
26. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.
Zhao G; Monier-Faugere MC; Langub MC; Geng Z; Nakayama T; Pike JW; Chernausek SD; Rosen CJ; Donahue LR; Malluche HH; Fagin JA; Clemens TL
Endocrinology; 2000 Jul; 141(7):2674-82. PubMed ID: 10875273
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo.
Qin X; Wergedal JE; Rehage M; Tran K; Newton J; Lam P; Baylink DJ; Mohan S
Endocrinology; 2006 Dec; 147(12):5653-61. PubMed ID: 16946002
[TBL] [Abstract][Full Text] [Related]
28. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
[TBL] [Abstract][Full Text] [Related]
29. Skeletal phenotype of the leptin receptor-deficient db/db mouse.
Williams GA; Callon KE; Watson M; Costa JL; Ding Y; Dickinson M; Wang Y; Naot D; Reid IR; Cornish J
J Bone Miner Res; 2011 Aug; 26(8):1698-709. PubMed ID: 21328476
[TBL] [Abstract][Full Text] [Related]
30. Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.
Wiren KM; Zhang XW; Olson DA; Turner RT; Iwaniec UT
Bone; 2012 Nov; 51(5):835-46. PubMed ID: 22910580
[TBL] [Abstract][Full Text] [Related]
31. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice.
Xiao Z; Dallas M; Qiu N; Nicolella D; Cao L; Johnson M; Bonewald L; Quarles LD
FASEB J; 2011 Jul; 25(7):2418-32. PubMed ID: 21454365
[TBL] [Abstract][Full Text] [Related]
32. Osteoblast AMP-activated protein kinase regulates glucose metabolism and bone mass in adult mice.
Kanazawa I; Takeno A; Tanaka KI; Notsu M; Sugimoto T
Biochem Biophys Res Commun; 2018 Sep; 503(3):1955-1961. PubMed ID: 30072101
[TBL] [Abstract][Full Text] [Related]
33. Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability.
Moon YJ; Yun CY; Choi H; Ka SO; Kim JR; Park BH; Cho ES
Exp Mol Med; 2016 Sep; 48(9):e256. PubMed ID: 27585718
[TBL] [Abstract][Full Text] [Related]
34. Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity.
Bartelt A; Beil FT; Müller B; Koehne T; Yorgan TA; Heine M; Yilmaz T; Rüther W; Heeren J; Schinke T; Niemeier A
Bone; 2014 May; 62():90-8. PubMed ID: 24440515
[TBL] [Abstract][Full Text] [Related]
35. Osteoblast-derived FGF9 regulates skeletal homeostasis.
Wang L; Roth T; Abbott M; Ho L; Wattanachanya L; Nissenson RA
Bone; 2017 May; 98():18-25. PubMed ID: 28189801
[TBL] [Abstract][Full Text] [Related]
36. Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals.
Misof BM; Roschger P; Tesch W; Baldock PA; Valenta A; Messmer P; Eisman JA; Boskey AL; Gardiner EM; Fratzl P; Klaushofer K
Calcif Tissue Int; 2003 Sep; 73(3):251-7. PubMed ID: 14667138
[TBL] [Abstract][Full Text] [Related]
37. Effects of Deletion of ERα in Osteoblast-Lineage Cells on Bone Mass and Adaptation to Mechanical Loading Differ in Female and Male Mice.
Melville KM; Kelly NH; Surita G; Buchalter DB; Schimenti JC; Main RP; Ross FP; van der Meulen MC
J Bone Miner Res; 2015 Aug; 30(8):1468-80. PubMed ID: 25707500
[TBL] [Abstract][Full Text] [Related]
38. Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.
Alioli CA; Demesmay L; Laurencin-Dalacieux S; Beton N; Farlay D; Follet H; Saber A; Duboeuf F; Chun J; Rivera R; Bouvard D; Machuca-Gayet I; Salles JP; Gennero I; Peyruchaud O
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158715. PubMed ID: 32330664
[TBL] [Abstract][Full Text] [Related]
39. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
Kim J; Xing W; Wergedal J; Chan JY; Mohan S
Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
[TBL] [Abstract][Full Text] [Related]
40. Gender specific LRP5 influences on trabecular bone structure and strength.
Dubrow SA; Hruby PM; Akhter MP
J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
